Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) reveals that the NHS could save over £6.9 billion in five years through quick adoption of new Diagnostic Tests as they come onto the market. In turn, these savings could help tackle the annual NHS shortfall, widely expected to reach £20 billion by 2022. Patients would benefit from three new tests – for heart attack, pre-eclampsia and inflammatory bowel disease – by reducing unnecessary procedures and medicationwhile delivering significant NHS savings. At the moment, the tests are used in only a handful of clinics and hospitals, although

The post New diagnostic tests could save Nhs Billions appeared first on The Hippocratic Post.